Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Baricitinib was effective in treating both early and late onset alopecia areata.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Estrogen therapy can reduce skin aging but has cancer risks.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

The combined therapy effectively treats androgenetic alopecia.

Adalimumab improved folliculitis decalvans in most patients.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Dutasteride may help prevent prostate cancer, but more research is needed.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Combination therapy improves hair growth in advanced hair loss.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.